[{"id":"lee-jae-lyun","kind":"person","name":"Jae Lyun Lee","route":"/people/lee-jae-lyun/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/people/asia-pacific.ts","type":"changed","fields":[{"field":"tldr","before":"\"A genitourinary oncologist who brought Korean cohorts into the enfortumab, pembrolizumab, and PARP-inhibitor GU trials.\"","after":"\"Jae Lyun Lee is a genitourinary oncologist who brought Korean cohorts into the enfortumab, pembrolizumab, and PARP-inhibitor GU trials.\""}]},{"id":"lee-jae-lyun","kind":"person","name":"Jae Lyun Lee","route":"/people/lee-jae-lyun/","commit":"9b4eb0eb88","date":"2026-09-08","author":"Jude Gomila","message":"Add Asia-Pacific, Canada, Brazil, and IARC/WHO people (91 person entities)","file":"src/data/people/asia-pacific.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"role"},{"field":"institutionId"},{"field":"institutions"},{"field":"specialisms"},{"field":"tldr"},{"field":"summary"},{"field":"profiles"},{"field":"papers"},{"field":"cancers"},{"field":"drugs"},{"field":"trials"}]}]